REVERSION OF RECENT-ONSET ATRIAL-FIBRILLATION TO SINUS RHYTHM BY INTRAVENOUS FLECAINIDE

被引:53
作者
DONOVAN, KD [1 ]
DOBB, GJ [1 ]
COOMBS, LJ [1 ]
LEE, KY [1 ]
WEEKES, JN [1 ]
MURDOCK, CJ [1 ]
CLARKE, GM [1 ]
机构
[1] ROYAL PERTH HOSP,DEPT CARDIOL,PERTH,WA 6001,AUSTRALIA
关键词
D O I
10.1016/0002-9149(91)90435-N
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Spontaneous reversion to sinus rhythm is a frequent occurrence in recent-onset atrial fibrillation (AF). In a randomized, double-blind, controlled study, intravenous flecainide (2 mg/kg, maximum dose 150 mg) was compared with placebo in the treatment of recent-onset AF (present for greater-than-or-equal-to 30 minutes and less-than-or-equal-to 72 hours' duration and a ventricular response greater-than-or-equal-to 120 beats/min). Intravenous digoxin (500-mu-g) was administered concurrently to all patients in both groups who had not previously taken digoxin. The trial medication was administered over 30 minutes. Exclusion criteria included hemodynamic instability, severe heart failure, recent antiarrhythmic therapy, hypokalemia and pacemaker dependence. One hundred two consecutive patients with recent-onset AF were enrolled in the study. All patients underwent continuous electrocardiographic monitoring in the intensive care or coronary care unit. Twenty-nine (57%) patients given flecainide and digoxin, but only 7 (14%) given placebo and digoxin, reverted to sinus rhythm in less-than-or-equal-to 1 hour after starting the trial medication infusion and remained in stable sinus rhythm (chi-square 18.9, p = 0.000013; odds ratio 8.3, 95% confidence interval 2.9 to 24.8). At the end of the 6-hour monitoring period, 34 patients (67%) in the flecainide-digoxin group were in stable sinus rhythm, whereas only 18 patients (35%) in the placebo-digoxin group had reverted (chi-square 8.83, p = 0.003; odds ratio 3.67, 95% confidence interval 1.5 to 9.1). Severe hypotension, although transient, was more common in the flecainide-digoxin group. Flecainide is effective in reverting recent-onset AF, but should not be given to patients with severe left ventricular dysfunction because the risks may outweight the potential benefits of reversion to sinus rhythm.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 25 条
  • [1] EFFICACY AND SAFETY OF FLECAINIDE ACETATE FOR ATRIAL TACHYCARDIA OR FIBRILLATION
    BERNS, E
    RINKENBERGER, RL
    JEANG, MK
    DOUGHERTY, AH
    JENKINS, M
    NACCARELLI, GV
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (15) : 1337 - 1341
  • [2] CLINICAL USEFULNESS OF FLECAINIDE ACETATE IN THE TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR ARRHYTHMIAS
    CAMM, AJ
    HELLESTRAND, KJ
    NATHAN, AW
    BEXTON, RS
    [J]. DRUGS, 1985, 29 : 7 - 13
  • [3] CAMPBELL TJ, 1985, BRIT HEART J, V54, P86
  • [4] CHOUTY F, 1988, AM J CARDIOL, V62, pD35
  • [5] RANDOMIZED PLACEBO-CONTROLLED TRIAL OF PROPAFENONE FOR TREATMENT OF ATRIAL TACHYARRHYTHMIAS AFTER CARDIAC-SURGERY
    CONNOLLY, SJ
    MULJI, AS
    HOFFERT, DL
    DAVIS, C
    SHRAGGE, BW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (05) : 1145 - 1148
  • [6] FLECAINIDE ACETATE FOR CONVERSION OF ACUTE SUPRAVENTRICULAR TACHYCARDIA TO SINUS RHYTHM
    CROZIER, IG
    IKRAM, H
    KENEALY, M
    LEVY, L
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (06) : 607 - 609
  • [7] ANTIARRHYTHMIC EFFICACY OF INTRAVENOUS THERAPY WITH DISOPYRAMIDE PHOSPHATE
    DEANO, DA
    WU, D
    MAUTNER, RK
    SHERMAN, RH
    EHSANI, AE
    ROSEN, KM
    [J]. CHEST, 1977, 71 (05) : 597 - 606
  • [8] DIGOXIN FOR CONVERTING RECENT-ONSET ATRIAL-FIBRILLATION TO SINUS RHYTHM - A RANDOMIZED, DOUBLE-BLINDED TRIAL
    FALK, RH
    KNOWLTON, AA
    BERNARD, SA
    GOTLIEB, NE
    BATTINELLI, NJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (04) : 503 - 506
  • [9] EFFICACY OF IV AMIODARONE IN CONVERTING RAPID ATRIAL-FIBRILLATION AND FLUTTER TO SINUS RHYTHM IN INTENSIVE-CARE PATIENTS
    FANIEL, R
    SCHOENFELD, P
    [J]. EUROPEAN HEART JOURNAL, 1983, 4 (03) : 180 - 185
  • [10] FENSTER PE, 1983, AM HEART J, V106, P510